Lista de obras - David A. Cairns - Dominio Público Uruguay

89 Development and external validation of a multivariable model of pre-test likelihood of coronary artery disease based on a contemporary uk population, with comparison to existing risk models

scholarly article by James RJ Foley et al published June 2017 in Heart

A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease

artículo científico publicado en 2011

A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses

artículo científico publicado en 2011

An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis ⬇️

artículo científico publicado en 2015

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

artículo científico publicado en 2009

Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls

artículo científico publicado en 2008

Biomarkers and response to bevacizumab--response

artículo científico publicado en 2014

CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment ⬇️

artículo científico publicado en 2016

Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator

artículo científico publicado en 2017

Changes in the urinary proteome post-operatively in renal cancer patients - a reflection of tumour or kidney removal?

artículo científico publicado en 2009

Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials ⬇️

artículo científico publicado en 2018

Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure ⬇️

artículo científico publicado en 2016

Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

artículo científico publicado en 2020

Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study ⬇️

artículo científico publicado en 2018

Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma

scientific article published on 10 June 2020

Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial ⬇️

artículo científico

Genetic factors influencing the risk of multiple myeloma bone disease ⬇️

artículo científico publicado en 2015

Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma ⬇️

artículo científico publicado en 2016

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-l

artículo científico publicado en 2014

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

artículo científico publicado en 2005

Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations

artículo científico publicado en 2010

Integrated multi-level quality control for proteomic profiling studies using mass spectrometry

artículo científico publicado en 2008

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

artículo científico publicado en 2018

Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT ⬇️

article

NuMA overexpression in epithelial ovarian cancer ⬇️

artículo científico publicado en 2012

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial

scientific article published on 12 July 2020

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification ⬇️

artículo científico publicado en 2016

Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection

artículo científico publicado en 2013

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. ⬇️

artículo científico publicado en 2017

Proteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age.

artículo científico publicado en 2013

Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model

artículo científico publicado en 2009

Proteomic profiling using mass spectrometry--does normalising by total ion current potentially mask some biological differences?

artículo científico publicado en 2008

Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study ⬇️

artículo científico publicado en 2018

Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart Failure ⬇️

artículo científico publicado en 2017

Retinoic acid-induced protein 3: identification and characterisation of a novel prognostic colon cancer biomarker

artículo científico publicado en 2012

Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison

artículo científico publicado en 2009

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

artículo científico publicado en 2022

Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation

artículo científico publicado en 2013

Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?

artículo científico

Statistical issues in quality control of proteomic analyses: Good experimental design and planning ⬇️

artículo científico publicado el 7 de febrero de 2011

Statistical issues in the design and planning of proteomic profiling experiments

artículo científico publicado en 2015

Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial ⬇️

artículo científico publicado en 2016

The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial ⬇️

artículo científico publicado en 2016

The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation ⬇️

The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

artículo científico publicado en 2019

The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma

artículo científico publicado en 2010

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial

artículo científico publicado en 2019

The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): stu ⬇️

artículo científico publicado en 2018

Urinary biomarker profiling in transitional cell carcinoma

artículo científico publicado en 2006

Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles--initial evaluation using low molecular weight serum peaks

artículo científico publicado en 2009

miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth ⬇️

artículo científico publicado en 2015

Lista de obras de David A. Cairns

89 Development and external validation of a multivariable model of pre-test likelihood of coronary artery disease based on a contemporary uk population, with comparison to existing risk models

A pilot study to investigate the potential of mass spectrometry profiling in the discovery of novel serum markers in chronic renal disease

A systematic analysis of the effects of increasing degrees of serum immunodepletion in terms of depth of coverage and other key aspects in top-down and bottom-up proteomic analyses

An analysis of the impact of pre-analytical factors on the urine proteome: Sample processing time, temperature, and proteolysis ⬇️

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls

Biomarkers and response to bevacizumab--response

CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment ⬇️

Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator

Changes in the urinary proteome post-operatively in renal cancer patients - a reflection of tumour or kidney removal?

Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials ⬇️

Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure ⬇️

Copy number evolution and its relationship with patient outcome-an analysis of 178 matched presentation-relapse tumor pairs from the Myeloma XI trial

Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study ⬇️

Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma

Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical Trial ⬇️

Genetic factors influencing the risk of multiple myeloma bone disease ⬇️

Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma ⬇️

High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-l

Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry

Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations

Integrated multi-level quality control for proteomic profiling studies using mass spectrometry

Maintenance Treatment and Survival in Patients With Myeloma: A Systematic Review and Network Meta-analysis

Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT ⬇️

NuMA overexpression in epithelial ovarian cancer ⬇️

Optimising the value of immunomodulatory drugs during induction and maintenance in transplant ineligible patients with newly diagnosed multiple myeloma: results from Myeloma XI, a multicentre, open-label, randomised, Phase III trial

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification ⬇️

Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection

Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients. ⬇️

Proteomic analysis of formalin-fixed paraffin-embedded renal tissue samples by label-free MS: assessment of overall technical variability and the impact of block age.

Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labelling of a von Hippel-Lindau transfectant cell line model

Proteomic profiling using mass spectrometry--does normalising by total ion current potentially mask some biological differences?

Quality of life during and following sequential treatment of previously untreated patients with multiple myeloma: findings of the Medical Research Council Myeloma IX randomised study ⬇️

Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart Failure ⬇️

Retinoic acid-induced protein 3: identification and characterisation of a novel prognostic colon cancer biomarker

Sample size determination in clinical proteomic profiling experiments using mass spectrometry for class comparison

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation

Serum biomarker discovery in renal cancer using 2-DE and prefractionation by immunodepletion and isoelectric focusing; increasing coverage or more of the same?

Statistical issues in quality control of proteomic analyses: Good experimental design and planning ⬇️

Statistical issues in the design and planning of proteomic profiling experiments

Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial ⬇️

The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial ⬇️

The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation ⬇️

The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial

The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma

The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial

The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): stu ⬇️

Urinary biomarker profiling in transitional cell carcinoma

Using the protein chip interface with quadrupole time-of-flight mass spectrometry to directly identify peaks in SELDI profiles--initial evaluation using low molecular weight serum peaks

miR-17-92 fine-tunes MYC expression and function to ensure optimal B cell lymphoma growth ⬇️